Patent · US Active

Compound signamycin, method for production thereof, and use thereof

US8058455B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

KINKI UNIVERSITY · JP

Inventors

Masayuki Igarashi · Tokyo, JP
Ryutaro Utsumi · Amagasaki, JP

Key dates

Filing date	Feb 23, 2011
Grant date	Nov 15, 2011
Priority date	—
Expiry date	Feb 23, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/465
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound having a structure expressed by the following Structural Formula (1) and a compound having a structure expressed by the following Structural Formula (2):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.